48 related articles for article (PubMed ID: 12461781)
41. RB1, development, and cancer.
Chinnam M; Goodrich DW
Curr Top Dev Biol; 2011; 94():129-69. PubMed ID: 21295686
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.
Zhang MG; Lee JY; Gallo RA; Tao W; Tse D; Doddapaneni R; Pelaez D
Pharmacol Res; 2018 Mar; 129():365-374. PubMed ID: 29203441
[TBL] [Abstract][Full Text] [Related]
43. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.
Casciano F; Zauli E; Busin M; Caruso L; AlMesfer S; Al-Swailem S; Zauli G; Yu AC
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509256
[TBL] [Abstract][Full Text] [Related]
44. Identification of the novel role of pRB in eye cancer.
Lai H; Ma F; Lai S
J Cell Biochem; 2003 Jan; 88(1):121-7. PubMed ID: 12461781
[TBL] [Abstract][Full Text] [Related]
45. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.
Di Fiore R; D'Anneo A; Tesoriere G; Vento R
J Cell Physiol; 2013 Aug; 228(8):1676-87. PubMed ID: 23359405
[TBL] [Abstract][Full Text] [Related]
46. The retinoblastoma protein and the cell cycle.
Sopta M; Gallie BL; Gill RM; Hamel PA; Muncaster M; Zacksenhaus E; Phillips RA
Semin Cancer Biol; 1992 Jun; 3(3):107-13. PubMed ID: 1511153
[TBL] [Abstract][Full Text] [Related]
47. [Genomic retinoblastoma perspectives: implications of tumor supressor gene RB1].
RodrÃguez-Cruz M; del Prado M; Salcedo M
Rev Invest Clin; 2005; 57(4):572-81. PubMed ID: 16315642
[TBL] [Abstract][Full Text] [Related]
48. Genetics of primary intraocular tumors.
Nagarkatti-Gude N; Wang Y; Ali MJ; Honavar SG; Jager MJ; Chan CC
Ocul Immunol Inflamm; 2012 Aug; 20(4):244-54. PubMed ID: 22834783
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
